Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
Last month, the German Federal Administrative Court issued a decision holding that, under certain circumstances, umbrella trademarks may be used for a portfolio of pharmaceutical products...
Last month, the German Federal Administrative Court issued a
decision holding that, under certain circumstances, umbrella
trademarks may be used for a portfolio of pharmaceutical products
with different active ingredients where the products are labeled in
the same indication and have a similar mode of action. However,
whether physicians and consumers are misled by an umbrella, or
common, trademark for products with different active ingredients
must be decided on a case-by-case basis.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
